Baseline requirements for novel agents being considered for phase II/III brain cancer efficacy trials: conclusions from the Adult Brain Tumor Consortium's first workshop on CNS drug delivery. Issue 10 (7th June 2020)

Record Type:: Journal Article
Title:: Baseline requirements for novel agents being considered for phase II/III brain cancer efficacy trials: conclusions from the Adult Brain Tumor Consortium's first workshop on CNS drug delivery. Issue 10 (7th June 2020)
Main Title:: Baseline requirements for novel agents being considered for phase II/III brain cancer efficacy trials: conclusions from the Adult Brain Tumor Consortium's first workshop on CNS drug delivery
Authors:: Grossman, Stuart A
Romo, Carlos G
Rudek, Michelle A
Supko, Jeffrey
Fisher, Joy
Nabors, L Burt
Wen, Patrick Y
Peereboom, David M
Ellingson, Benjamin M
Elmquist, William
Barker, Fred G
Kamson, David
Sarkaria, Jann N
Timmer, William
Bindra, Ranjit S
Ye, Xiaobu
Abstract:
Is Part Of:: Neuro-oncology. Volume 22:Issue 10(2020)
Journal:: Neuro-oncology
Issue:: Volume 22:Issue 10(2020)
Issue Display:: Volume 22, Issue 10 (2020)
Year:: 2020
Volume:: 22
Issue:: 10
Issue Sort Value:: 2020-0022-0010-0000
Page Start:: 1422
Page End:: 1424
Publication Date:: 2020-06-07
Subjects:: Brain Neoplasms -- Periodicals
Brain -- Tumors -- Periodicals
Brain -- Cancer -- Periodicals
Nervous system -- Cancer -- Periodicals
616.99481
Journal URLs:: http://neuro-oncology.dukejournals.org/ ↗
http://neuro-oncology.oxfordjournals.org/ ↗
http://www.oxfordjournals.org/content?genre=journal&issn=1522-8517 ↗
http://ukcatalogue.oup.com/ ↗
DOI:: 10.1093/neuonc/noaa142 ↗
Languages:: English
ISSNs:: 1522-8517
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 6081.288000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 15106.xml